Long-term goflkicept therapy for patients with idiopathic recurrent pericarditis: results of the interim analysis of an ongoing open-label extension study

Autor: Valentina Yu. Myachikova, Alexey L. Maslyanskiy, Olga M. Moiseeva, Margarita L. Schedrova, Alina N. Egorova, Еkaterina G. Ponomar, Mikhail Yu. Samsonov

Publikováno v: Терапевтический архив, Vol 96, Iss 09, Pp 892-900 (2024)

Aim. To evaluate the long-term safety and efficacy of goflkicept treatment in patients with idiopathic recurrent pericarditis (IRP). Materials and methods. This report presents the interim analysis of an ongoing open-label extension (OLE) clinical

Externí odkaz: https://doaj.org/article/b05eb9ec1ac34696b30bb4daa7622294

Main circulating CD8+ T cell subsets in patients with systemic lupus erythematosus

Autor: S. S. Benevolenskaya, I. V. Kudriavtsev, M. K. Serebriakova, A. A. Rubinstein, E. S. Kuvardin, I. N. Grigor’yeva, D. B. Aliev, D. B. Zammoeva, D. B. Motorin, A. S. Golovkin, O. V. Kalinina, S. V. Lapin, I. Z. Gaydukova, A. L. Maslyanskiy, E. K. Gaydukova

Publikováno v: Научно-практическая ревматология, Vol 62, Iss 1, Pp 90-97 (2024)

Relevance. Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of immune tolerance and sustained production of autoantibodies.The aim of the study – to compare composition of peripheral blood cytotoxic CD8+ T lymphocyt

Externí odkaz: https://doaj.org/article/620ec49b1c9e4f4dabb149a8ef66de1b

Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study

Autor: Maid, Pablo, Rillo, Oscar, Inderjeeth, Charles, Scheinecker, Clemens, Hermann, Josef, Marcolino, Flora Maria D'Andrea, Dias, Laiza H, Scafuto, Antonio, Bookman, Arthur AM, Fortin, Isabelle, Morin, Frederic, Goio, Elizabeth Jean Moreno, Pezo Ruiz, Ninette, Roman Zamoran, Carlos Patricio, Gonzalez Abarzua, Ivan Antonio, Elgueta, Sergio Fabian, Forero Illera, Elias Gonzalo, Marquez Herndez, Javier Dario, Garcia, Alex Echeverri, Pensec, Valerie Devauchelle, Hachulla, Eric, Mariette, Xavier, Gottenberg, Jacques-Eric, Le Guern, Veronique, Finzel, Stephanie, Schaefer, Valentin, Tony, Hans-Peter, Thomas Schmalzing, Marc, Tausche-Wunderlich, Anne-Kathrin, Tzioufas, Athanasios, Balog, Attila, Rojkovich, Bernadette, Varga, Tunde, Lidar, Merav, Rosner, Itzhak, Levy, Yair, Dagna, Lorenzo, Mosca, Marta, Quartuccio, Luca, Nishiyama, Susumu, Kodera, Masanari, Kaneko, Yuko, Okada, Masato, Ueki, Yukitaka, Hwan Park, Sung, van Daele, Paulus Leon Arthur, Bootsma, Hendrika, Duarte Barcelos, Filipe Alexandre, Crispim Romao, Vasco Madeira, Raimundo Vinagre, Filipe Manuel, Tavaresda Costa, Jose Antonio, Rednic, Simona, Duca, Liliana, Maslyanskiy, Alexey, Yakupova, Svetlana, Bugrova, Olga, Izmozherova, Nadezhda, Zotkin, Evgenyi, Nikolaevna Anoshenkova, Olga, Kvarnstrom, Marika, Tufan, Abdurrahman, Fisher, Benjamin, Yee, Chee Seng, Parker, Benjamin Joseph, Grader Beck, Thomas, Lawrence Ford, Theresa, Papas, Athena, Carsons, Steven, Thiagarajan, Saravanan, Zero, Domenick, McCoy, Sara, Sandorfi, Nora, Fisher, Benjamin A ^*, Grader-Beck, Thomas, Ng, Wan-Fai, van Daele, P L A, Noaiseh, Ghaith, Elgueta, Sergio, McCoy, Sara S, Akpek, Esen, Bookman, Arthur, Sopala, Monika, Montecchi-Palmer, Michela, Luo, Wen-Lin, Scheurer, Cornelia, Hueber, Wolfgang ^*

Publikováno v: In The Lancet 10-16 August 2024 404(10452):540-553

Clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis

Autor: E. S. Kuvardin, D. Yu. Andreev, P. A. Yastrebov, V. Yu. Myachikova, D. V. Bukhanova, D. V. Karpova, K. N. Malikov, M. Yu. Samsonov, A. L. Maslyanskiy

Publikováno v: Научно-практическая ревматология, Vol 60, Iss 5, Pp 603-608 (2022)

Treatment algorithms for systemic sclerosis have not been completely developed. Effectivity of medications are usually used in clinical practice has a low level of evidence. Therefore, it is necessary to find a new treatment approaches for this nosol

Externí odkaz: https://doaj.org/article/74c94962383a46af9b50fe955058831b

Experience of successful autologous hematopoietic stem cell transplantation in patients with an unfavorable prognosis of systemic scleroderma

Autor: V. I. Mazurov, A. L. Maslyanskiy, K. E. Zotkina, S. S. Benevolenskaya, D. V. Motorin, A. Yu. Zaritskiy, E. A. Vasilenko, A. A. Vasilenko, A. M. Titova

Publikováno v: Научно-практическая ревматология, Vol 60, Iss 3, Pp 381-387 (2022)

One of the methods of treating severe forms of systemic scleroderma is hematopoietic stem-cell autotransplantation (auto-HSCT). The article describes two clinical cases of auto-HSCT followed by rituximab (RTM) therapy in patients with diffuse systemi

Externí odkaz: https://doaj.org/article/4634e492ce7a4de98e6bca577f198bdd